Home LiteratureArticle Details
PMID: 3234427 Published · ppublish English Journal Article

Immunological changes in human breast cancer.

European journal of gynaecological oncology ·Vol. 9 ·No. 6 ·1988-00-00 ·Pages 502-14

Contreras Ortiz O, Stoliar A

Abstract

In 38 breast cancer patients were examined the following immune system parameters: total and active T lymphocytes; killer cells; bastogenic response to Phytohaemaglutinin; leucocyte migration inhibition test with autologous tumor extract; serum immunoglobulins and phagocytosis and intracellular killing of Candida albicans. The immunological evaluations were made in pre-surgery and after each 3 months, during 18 months. In stage I practically there was no difference with controls. The active T lymphocytes were significant decreased until 15 months post surgery in stage II and in all samples stages III and IV. The response to Phytohaemaglutinin was diminished in all samples of stages II, III and IV. A recognition and sensitiveness to tumoral antigen were observed until 6 months post surgery in stage I and during checking time in the others stages. Respect to the phagocytic function only the intracellular killing mechanism failed at 3 months post surgery.

MeSH Terms
Aged Axilla Breast Neoplasms/immunology,pathology,surgery Female Humans Immunity, Cellular Killer Cells, Natural/physiology Lymph Nodes/immunology Middle Aged Neoplasm Staging Prognosis
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Contreras Ortiz O
SEGBA Gynecology Department - Buenos Aires, Argentina.
Stoliar A
Article Info
Journal
European journal of gynaecological oncology
Abbr.
Eur J Gynaecol Oncol
ISSN
0392-2936
Published
1988-00-00
Pages
502-14
Language
English
Region
China
NLM ID
8100357
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com